Company profile for CARA Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Cara Therapeutics is a clinical-stage biotechnology company located in Stamford, CT focused on developing and commercializing new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed. We aim to achieve this by developing new products that selectively target the body’s peripheral kappa opioid receptors. Cara is developing a novel and proprietary class of product candida...
Cara Therapeutics is a clinical-stage biotechnology company located in Stamford, CT focused on developing and commercializing new chemical entities designed to fundamentally change the way acute pain, chronic pain and pruritus are managed. We aim to achieve this by developing new products that selectively target the body’s peripheral kappa opioid receptors. Cara is developing a novel and proprietary class of product candidates that target the body’s peripheral nervous system and have demonstrated initial efficacy in patients with moderate-to-severe pain and pruritus (itch).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4 Stamford Plaza 107 Elm Street, 9th Floor Stamford, CT 06902
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/04/15/3062122/0/en/Tvardi-Therapeutics-Announces-Closing-of-Merger-with-Cara-Therapeutics.html

GLOBENEWSWIRE
15 Apr 2025

https://www.globenewswire.com/news-release/2025/04/14/3061132/0/en/Cara-Therapeutics-Announces-1-for-3-Reverse-Stock-Split-in-Connection-with-the-Proposed-Merger-with-Tvardi-Therapeutics.html

GLOBENEWSWIRE
14 Apr 2025

https://www.globenewswire.com/news-release/2024/12/27/3002215/0/en/Cara-Therapeutics-Announces-Effective-Date-of-1-for-12-Reverse-Stock-Split.html

GLOBENEWSWIRE
27 Dec 2024

https://www.globenewswire.com/news-release/2024/12/18/2998930/0/en/Cara-Therapeutics-and-Tvardi-Therapeutics-Announce-Entry-into-Merger-Agreement.html

GLOBENEWSWIRE
18 Dec 2024

https://www.globenewswire.com/news-release/2024/07/11/2911690/29236/en/Cara-Therapeutics-Announces-Exploration-of-Strategic-Alternatives.html

GLOBENEWSWIRE
11 Jul 2024

https://www.reuters.com/business/healthcare-pharmaceuticals/cara-therapeutics-discontinues-study-neurological-condition-drug-fails-2024-06-12/

REUTERS
13 Jun 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty